A MALDI-TOF system shall be procured for multiplex pharmacogenic genotyping for the Department of Pharmacology at Oslo University Hospital. The analysis instrument shall be able to carry out genotyping of a clinically re…
levant selection of pharmacogenetic variants, state special CYP2D6 gene lesions and duplications/multiplications, as well as some CYP2D6 genhybrides (compound genes). The analysis system must be able to use the manufacturer ́s ready designed panels, at the same time that self-designed analysis panel
s must be established for clinical use and/or research. The system must have a uniform protocol and workflow and have capacity that provides an expected laboratory engineering turnaround of 2 work days for analysing the specified pharmacoge